Article

In-office versus wholesale labs

Author(s):

As more and more ophthalmologists choose to provide full-service patient care, including eyewear dispensing, the relevant and growing complexities to the choice between an in-office edging lab approach versus an off-site, wholesale finishing lab solution have become increasingly important.

Breakthroughs in coatings, lens material base, and substrate technology provide patients with greater visual acuity and comfort than ever before. The introduction, acceptance, and widespread use of new materials-such as Trivex, super-hyrdophobic, and anti-reflective coatings-and innovative lens-fabrication processes-such as digital surfacing-evidence this trend.

Advancements in technologies-such as the "trace-and-transmit" method-have become much more viable as the costs of new lenses and treatments have increased. Trace-and-transmit is where frame and patient data are sent directly to a wholesale lab, rather than on-site lens edging performed by the dispensing practice. (See Figures 1 and 2.)

A long-standing industry estimate notes that 52% of all optical lens edging is performed at retail locations, whereas 48% is done at wholesale labs. The complexities and potential costs/risks of on-site lens processing have set the stage for a dramatic shift in where patient lenses will get finished over the next 2 to 4 years.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
© 2025 MJH Life Sciences

All rights reserved.